Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Prescient Therapeutics, Ltd.
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Barbara Ann Karmanos Cancer Institute
Stanford University
City of Hope Medical Center
Thomas Jefferson University
Washington University School of Medicine
University College, London
4SC AG
Emory University
Kyowa Kirin Co., Ltd.
European Organisation for Research and Treatment of Cancer - EORTC
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
University of Nebraska
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Genmab
Stanford University
Genmab
Atara Biotherapeutics
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Elorac, Inc.
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
4SC AG
Northwestern University
European Organisation for Research and Treatment of Cancer - EORTC
Roswell Park Cancer Institute
AbbVie
Rochester General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Northwestern University